Jamie Clark
Stock Analyst at Rothschild & Co
(1.90)
# 3,193
Out of 5,141 analysts
9
Total ratings
57.14%
Success rate
2.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $241.12 | +28.98% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $453.77 | +4.46% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $99.70 | +136.71% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $168.92 | +7.74% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $282.67 | -2.36% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $202.41 | -3.66% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $165.62 | +66.65% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $241.12
Upside: +28.98%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $453.77
Upside: +4.46%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $99.70
Upside: +136.71%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $168.92
Upside: +7.74%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $282.67
Upside: -2.36%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $202.41
Upside: -3.66%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $165.62
Upside: +66.65%